NEW YORK–( BUSINESS WIRE )– Schrödinger today announced the appointment of Nancy Thornberry, a biotech executive recognized for her extensive track record in drug discovery and development, to its Board of Directors. Ms. Thornberry, the Chief Executive Officer of Kallyope Inc., brings over 30 years of biopharma leadership to […]
Click here to view original web page at www.businesswire.com
